Changes in use of antiretroviral therapy in regions of Europe over time

Ole Kirk(University of Copenhagen), Jens Lundgren(Centre of Excellence for Health, Immunity and Infections), Juan Gonzales-Lahoz(Instituto de Salud Carlos III), Francisco Antunes(University of Lisbon), Jacqueline Parkin(CTI BioPharma (United Kingdom)), Terese L. Katzenstein, Amanda Mocroft(University of Copenhagen), P Francioli(University of Lusaka), Ray P. Brettle(City Hospital), Adriano Lazzarin(Vita-Salute San Raffaele University)
AIDS
October 1, 1998
10.1097/00002030-199815000-00015
Cited by 64

Related Papers

Industrial enzyme applications
|Current Opinion in Biotechnology|2002|1.5k
Sexual Activity Without Condoms and Risk of HIV Transmission in Serodifferent Couples When the HIV-Positive Partner Is Using Suppressive Antiretroviral Therapy
|JAMA|2016|1.4k
Decline in the AIDS and death rates in the EuroSIDA study: an observational study
|The Lancet|2003|1.2k
Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study
|The Lancet|2019|1k
Cardiovascular disease risk factors in HIV patients – association with antiretroviral therapy. Results from the DAD study
|AIDS|2003|987